NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: Arizona State University
Conditions: Methamphetamine Abuse, Hiv, Social Stigma
Interventions: Methamphetamine, PrEP, and Intersectional Stigma (eMPrISe) study
The goal of this clinical trail is to test the developed eMPrISe study in HIV-negative, adult, Latino men who have sex with men (MSM) who use non-injection substances. The main questions it aims to answer are: * Can participation in the developed eMPrISe study reduce methamphetamine ('meth') use risk? * Can participation in the developed eMPrISe study improve preexposure prophylaxis (PrEP) cascade progression? Participants will participate in 12 weekly modules that: (1) build critical thinking skills, (2) identify and discuss the link between oppression and harmful behaviors, (3) take action, (4) voice and validate feelings and experiences, and (5) share knowledge and resources.
Sex: MALE
Age: 18 Years to —
Healthy volunteers: No
Study type: INTERVENTIONAL
Inclusion Criteria: * 18+ years of age * cisgender male * self-identify as Latino or Hispanic * fluent in English or Spanish * any sexual activity with men in the past 12 months * HIV-negative * moderate methamphetamine use risk (as determined by the the ASSIST assessment) * experience of intersectional stigma within their social network in the past 12 months * willing to provide written informed consent Exclusion Criteria: * N/A